SCHEMBL2525512

SCHEMBL2525512

OC(c1cccnc1)c1c(-c2ccc(F)cc2F)coc1-c1ccc(Cl)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KCNA5 P22460 3/20 0.33
TSHR P16473 1/20 0.33
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32
ACKR3 P25106 2/20 0.31
CYP3A4 P08684 1/20 0.31
PDE10A Q9Y233 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
ADRB2 P07550 1/20 0.31
ADRB1 P08588 1/20 0.31
ADRB3 P13945 1/20 0.31
GAA P10253 1/20 0.31
CYP17A1 P05093 1/20 0.31
PRKDC P78527 1/20 0.31
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2518694 0.93 CYP2A6 (0.37) CYP2A6SMN1; SMN2LMNAL3MBTL1KCNA5
SCHEMBL2522100 0.92 CYP2A6 (0.38) CYP2A6SMN1; SMN2LMNAL3MBTL1KCNA5
SCHEMBL14465922 0.88 CYP2A6 (0.34) CYP2A6SMN1; SMN2LMNAL3MBTL1TSHR
SCHEMBL2519754 0.86 CYP2A6 (0.37) CYP2A6SMN1; SMN2LMNAL3MBTL1KCNA5
SCHEMBL2520440 0.85 TSHR (0.43) CYP2A6SMN1; SMN2LMNAL3MBTL1KCNA5
SCHEMBL2520591 0.84 CYP2A6 (0.41) CYP2A6SMN1; SMN2LMNAL3MBTL1KCNA5
SCHEMBL2525502 0.84 CYP19A1 (0.36) SMN1; SMN2LMNAL3MBTL1KCNA5CYP3A4
SCHEMBL2518698 0.84 CYP17A1 (0.39) SMN1; SMN2LMNAL3MBTL1KCNA5TSHR
SCHEMBL2194894 0.84 ATM (0.37) CYP2A6SMN1; SMN2LMNAL3MBTL1KCNA5
SCHEMBL2523941 0.84 CYP2A6 (0.42) CYP2A6SMN1; SMN2LMNAL3MBTL1KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110251069-A1 ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS SYNGENTA CROP PROTECTION LLC (US) 2011-10-13 US disclosed
US-20110251069-A1 ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS SYNGENTA CROP PROTECTION LLC (US) 2011-10-13 US disclosed
US-20110251069-A1 ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS SYNGENTA CROP PROTECTION LLC (US) 2011-10-13 US disclosed
US-20070244162-A1 SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES SYNGENTA LIMITED (GB) 2007-10-18 US disclosed
US-20070244162-A1 SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES SYNGENTA LIMITED (GB) 2007-10-18 US disclosed
US-20070244162-A1 SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES SYNGENTA LIMITED (GB) 2007-10-18 US disclosed
WO-2007075487-A2 SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES SYNGENTA LIMITED (GB) 2007-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244162-A1 SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUNDS AS FUNGICIDES NOX5, CYP3A5, API5 CYP2A6 340/4885SMN1; SMN2 3172/4885LMNA 4216/4885
US-20110251069-A1 ISOXAZOLE DERIVATIVES FOR USE AS PLANT GROWTH REGULATORS FKBP5, FKBP2, FKBP1B CYP2A6 2016/4885SMN1; SMN2 4879/4885LMNA 4815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.